Streetbeat News

Legal

EIS

President Joe Biden has called for an immediate ceasefire in the Gaza war, marking a significant shift in U.S. policy towards Israel. This comes after an Israeli military operation killed seven individuals associated with the World Central Kitchen. The White House demands concrete actions from Israel to address civilian harm and ensure the safety of aid workers. In response, Israel has committed to adjusting its military tactics and promised a swift inquiry into the incident. Israeli stocks, including the iShares MSCI Israel ETF (EIS), have seen a significant drop following these developments.

Portfolio Pulse from Piero Cingari

April 04, 2024 | 8:58 pm

VAL

Valaris announced that ARO Drilling, its joint venture in Saudi Arabia, received a suspension notice from Aramco for one of its 19 contracted rigs, specifically the Jackup VALARIS 143. The rig's contract was set to end in December 2024, but the suspension could last up to twelve months. ARO is currently in discussions with Aramco to finalize the suspension's start date.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 8:17 pm

GME

Gamestop Corp. (GME) and its COO, Nir Patel, have agreed on a separation agreement and mutual release of claims, facilitating Mr. Patel's departure from the company, as per an SEC filing on April 4, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 8:17 pm

GOOG

GOOGL

YouTube has stated that OpenAI's use of its videos to train the AI model Sora would violate its policies. This announcement raises concerns about the use of publicly available data for AI training and could impact the relationship between content platforms and AI developers.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 6:59 pm

NTDOY

Pocketpair released a major update for Palworld, introducing the first raid boss, Bellanoir, and various new features and items. The update includes summoning Raid Boss Pals, Training Manuals, Recovery Meds, and the Homeward Thundercloud. It also addresses UI improvements, balancing, bug fixes, and anti-cheating measures. Despite controversy over being a Pokémon clone, leading to actions by Nintendo ADR (OTC:NTDOY), Palworld continues to grow, with the player base looking forward to more updates.

Portfolio Pulse from Franca Quarneti

April 04, 2024 | 6:48 pm

DJT

SPY

A recent court ruling has denied former President Donald Trump's attempt to dismiss a case concerning the handling of documents, based on his claim that they were 'personal' records. This development marks a significant moment in the ongoing legal challenges faced by Trump.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 6:46 pm

ABUS

MRNA

A Delaware District Court ruled in favor of Arbutus Biopharma Corporation (ABUS) and Genevant Sciences in their patent infringement lawsuit against Moderna Inc (MRNA) regarding Moderna's COVID-19 vaccine. The court's decision strengthens the plaintiffs' case by supporting their interpretation of the contested patent terms related to a lipid nanoparticle platform crucial for the vaccine's delivery. Arbutus and Genevant are seeking compensation for Moderna's use of this technology. JMP Securities maintains a Market Outperform rating on ABUS with a price target of $4. ABUS shares rose 3.25% to $3.02, while MRNA shares increased by 3.89% to $105.2.

Portfolio Pulse from Vandana Singh

April 04, 2024 | 6:32 pm

MRNA

Moderna's stock is experiencing a rebound after a decline on Wednesday due to Arbutus receiving permission to pursue a patent claim against Moderna. This legal development had initially negatively impacted Moderna's stock price.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:57 pm

GIL

HBI

The future of Gildan Activewear Inc. is under intense scrutiny as a series of events including the firing of its CEO, pressure from a rebel investor, and discussions about mergers and acquisitions (M&A) stir a significant battle for control and direction. These developments have put the spotlight on the company's strategic decisions and governance, raising questions about its next moves in the face of these challenges.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:36 pm

BNTX

CVAC

GSK

CureVac N.V. (CVAC) and GSK Plc (GSK) released interim data from their seasonal influenza vaccine study, showing promising results across all age groups and dose levels. The vaccine, designed for broad antigen coverage, demonstrated strong antibody titers and an acceptable safety profile. The study is part of a collaboration between CureVac and GSK, focusing on a multivalent vaccine candidate using CureVac's second-generation mRNA technology. Additionally, CureVac is involved in ongoing patent litigation with BioNTech SE (BNTX) over intellectual property rights.

Portfolio Pulse from Vandana Singh

April 04, 2024 | 4:18 pm